Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Takes $10M in Stimulus Orders

NEW YORK (GenomeWeb News) – Bruker said this week that it has taken in $10 million in orders due to stimulus programs in the US, Japan, and Europe.

The firm disclosed in a filing with the US Securities and Exchange Commission that by the end of August it had booked $10 million in orders due the various stimulus programs, with more than $3 million coming from Japan. It said that it had booked five system orders from that country.

In addition, Bruker said that it expected "significant" NMR, MRI, EPR, X-ray crystallography, high-end mass spectrometry, and other system orders during the third and fourth quarters of this year, and into 2010, due to the global stimulus programs.

Bruker also disclosed this information during a presentation this week at a Morgan Stanley institutional investors' conference in Zurich, Switzerland.

"We are encouraged by these orders and believe they will be a key driver f possible upside surprise in BRKR revenues," Leerink Swann analyst Isaac Ro wrote in a research note published today.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.